Publication | Closed Access

A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Gastrointestinal OncologyMedicinePlatinum Resistant/refractoryGynecologyFallopian TubeCancer TreatmentAnti-lewis-y Monoclonal AntibodyImmunotherapyOncologyRadiation OncologyGynecology OncologyOvarian Cancer